Parallel Advisors, LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 295 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$110,765
+6.7%
7,160
+8.4%
0.00%
+33.3%
Q2 2023$103,812
+24.1%
6,608
+30.2%
0.00%0.0%
Q1 2023$83,636
+55.3%
5,075
+47.0%
0.00%
+50.0%
Q4 2022$53,851
-63.4%
3,452
-69.6%
0.00%
-71.4%
Q3 2022$147,000
-2.0%
11,356
+6.0%
0.01%0.0%
Q2 2022$150,000
+3.4%
10,716
+6.4%
0.01%
+16.7%
Q1 2022$145,000
+46.5%
10,072
+38.8%
0.01%
+50.0%
Q4 2021$99,000
+2.1%
7,255
+22.7%
0.00%0.0%
Q3 2021$97,000
+27.6%
5,913
+30.4%
0.00%
+33.3%
Q2 2021$76,000
-12.6%
4,536
-4.7%
0.00%
-25.0%
Q1 2021$87,000
+26.1%
4,758
+25.1%
0.00%0.0%
Q4 2020$69,000
-12.7%
3,804
-13.6%
0.00%
-20.0%
Q3 2020$79,000
-1.2%
4,401
-2.5%
0.01%0.0%
Q2 2020$80,000
+110.5%
4,514
+80.2%
0.01%
+66.7%
Q1 2020$38,000
-2.6%
2,505
+27.6%
0.00%0.0%
Q4 2019$39,000
+50.0%
1,963
+30.1%
0.00%
+50.0%
Q3 2019$26,000
+271.4%
1,509
+276.3%
0.00%
+100.0%
Q2 2019$7,000
-78.8%
401
-75.3%
0.00%
-75.0%
Q1 2019$33,0001,6230.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2021
NameSharesValueWeighting ↓
Adelphi Capital LLP 7,931,116$140,381,00032.92%
Endurant Capital Management LP 932,967$16,514,0006.51%
Glenview Capital Management 26,430,828$467,826,0004.24%
Paulson & Co. 13,244,711$234,431,0003.98%
Blackcrane Capital, LLC 172,955$3,061,0003.88%
NINE MASTS CAPITAL Ltd 1,474,286$26,146,0003.74%
Velanne Asset Management Ltd 286,640$5,074,0003.22%
LMR Partners LLP 4,563,591$80,884,0002.95%
SECTOR GAMMA AS 796,299$14,094,0002.26%
MFN Partners Management, LP 785,000$13,895,0002.21%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders